Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sellman

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Antimicrobial Agents and Chemotherapy|December 18, 2019
Protective Efficacy of Monoclonal Antibodies Neutralizing Alpha-Hemolysin and Bicomponent Leukocidins in a Rabbit Model of Staphylococcus aureus Necrotizing PneumoniaTrang T T Vu, Nhu T Q Nguyen, Vuvi G Tran, et al.
Antimicrobial Agents and Chemotherapy|June 22, 2016
Staphylococcus aureus Alpha-Toxin Is Conserved among Diverse Hospital Respiratory Isolates Collected from a Global Surveillance Study and Is Neutralized by Monoclonal Antibody MEDI4893David E Tabor, Li Yu, Hoyin Mok, et al.
Antimicrobial Agents and Chemotherapy|April 27, 2021
Multimechanistic Monoclonal Antibody Combination Targeting Key Staphylococcus aureus Virulence Determinants in a Rabbit Model of Prosthetic Joint InfectionYanjie Mao, Florent Valour, Nhu T Q Nguyen, et al.
Immuno-Oncology Technology|June 27, 2022
Intervention strategies for microbial therapeutics in cancer immunotherapyV Gopalakrishnan, B Weiner, C B Ford, et al.
Clinical and Vaccine Immunology : CVI|January 13, 2012
Identification of anti-alpha toxin monoclonal antibodies that reduce the severity of Staphylococcus aureus dermonecrosis and exhibit a correlation between affinity and potencyC Tkaczyk, L Hua, R Varkey, et al.
The Journal of Clinical Investigation|May 3, 2017
Bispecific antibody targets multiple Pseudomonas aeruginosa evasion mechanisms in the lung vasculatureAjitha Thanabalasuriar, Bas Gj Surewaard, Michelle E Willson, et al.
Plos One|October 8, 2013
Staphylococcus aureus alpha toxin suppresses effective innate and adaptive immune responses in a murine dermonecrosis modelChristine Tkaczyk, Melissa M Hamilton, Vivekananda Datta, et al.
Clinical & Translational Immunology|July 31, 2019
Associations of pathogen-specific and host-specific characteristics with disease outcome in patients with <i>Staphylococcus aureus</i> bacteremic pneumoniaBatu K Sharma-Kuinkel, Christine Tkaczyk, Jessica Bonnell, et al.
Mbio|June 30, 2016
Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus DiseaseC Tkaczyk, M M Hamilton, A Sadowska, et al.
Science Translational Medicine|October 4, 2023
A protein-free vaccine stimulates innate immunity and protects against nosocomial pathogensJun Yan, Travis B Nielsen, Peggy Lu, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Antimicrobial Agents and Chemotherapy|December 18, 2019
Protective Efficacy of Monoclonal Antibodies Neutralizing Alpha-Hemolysin and Bicomponent Leukocidins in a Rabbit Model of Staphylococcus aureus Necrotizing PneumoniaTrang T T Vu, Nhu T Q Nguyen, Vuvi G Tran, et al.
Antimicrobial Agents and Chemotherapy|June 22, 2016
Staphylococcus aureus Alpha-Toxin Is Conserved among Diverse Hospital Respiratory Isolates Collected from a Global Surveillance Study and Is Neutralized by Monoclonal Antibody MEDI4893David E Tabor, Li Yu, Hoyin Mok, et al.
Antimicrobial Agents and Chemotherapy|April 27, 2021
Multimechanistic Monoclonal Antibody Combination Targeting Key Staphylococcus aureus Virulence Determinants in a Rabbit Model of Prosthetic Joint InfectionYanjie Mao, Florent Valour, Nhu T Q Nguyen, et al.
Immuno-Oncology Technology|June 27, 2022
Intervention strategies for microbial therapeutics in cancer immunotherapyV Gopalakrishnan, B Weiner, C B Ford, et al.
Clinical and Vaccine Immunology : CVI|January 13, 2012
Identification of anti-alpha toxin monoclonal antibodies that reduce the severity of Staphylococcus aureus dermonecrosis and exhibit a correlation between affinity and potencyC Tkaczyk, L Hua, R Varkey, et al.
The Journal of Clinical Investigation|May 3, 2017
Bispecific antibody targets multiple Pseudomonas aeruginosa evasion mechanisms in the lung vasculatureAjitha Thanabalasuriar, Bas Gj Surewaard, Michelle E Willson, et al.
Plos One|October 8, 2013
Staphylococcus aureus alpha toxin suppresses effective innate and adaptive immune responses in a murine dermonecrosis modelChristine Tkaczyk, Melissa M Hamilton, Vivekananda Datta, et al.
Clinical & Translational Immunology|July 31, 2019
Associations of pathogen-specific and host-specific characteristics with disease outcome in patients with <i>Staphylococcus aureus</i> bacteremic pneumoniaBatu K Sharma-Kuinkel, Christine Tkaczyk, Jessica Bonnell, et al.
Mbio|June 30, 2016
Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus DiseaseC Tkaczyk, M M Hamilton, A Sadowska, et al.
Science Translational Medicine|October 4, 2023
A protein-free vaccine stimulates innate immunity and protects against nosocomial pathogensJun Yan, Travis B Nielsen, Peggy Lu, et al.
Pageof 10